版本:
中国

BRIEF-Phase 1/2 clinical trial of Agenus' anti-PD-1 antibody begins

April 20 Agenus Inc

* Phase 1/2 clinical trial of Agenus' anti-PD-1 antibody begins

* Agenus Inc - Preliminary safety and efficacy data are expected to be available within next 9-12 months from AGEN2034 study Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐